All Activity

The Trump administration is backing away from a prior federal recommendation to limit alcohol consumption to specific amounts, even as marijuana remains federally criminalized and more Americans are choosing cannabis for personal health reasons. The U.S. Department of Agriculture (USDA) and Department of Health and Human Services (HHS) released updated dietary guidance on Wednesday, drawing criticism over the reversal of a recommendation that American men should limit alcohol consumption to a maximum of two drinks per day and women should consume no more than one drink per day. Cannabis isn’t addressed in the guidance. President Donald Trump doesn’t drink alcohol, but his administration is evidently skeptical about giving Americans specific recommendations about how much of it that Americans should consume. The new federal document also removes prior mentions of alcohol’s role in potentially increasing the risk of cancer, cardiovascular disease and death. Trump also doesn’t smoke marijuana, but so far the administration has only taken the incremental—albeit contextually historic—step of directing the completion of a process to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). That would not legalize marijuana, but it would remove certain research restrictions and allow cannabis businesses to take federal tax deductions. Meanwhile, alcohol is not considered a federally controlled substance at all. It’s subject to regulations, but its use and sale for adults has been normalized—even if many Americans are starting to shift away from drinking and more adults have found an alternative in marijuana. “Alcohol is a social lubricant that brings people together,” Centers for Medicare & Medicaid Services Mehmet Oz said at a White House briefing on Wednesday. “In the best-case scenario, I don’t think you should drink alcohol, but it does allow people an an excuse to bond and socialize, and there’s probably nothing healthier than having a good time with friends in a safe way.” The alcohol industry is cheering the Trump administration’s changes to the guidance. “Americans deserve a balanced and unbiased approach to recommendations on alcohol consumption and this is exactly what we got today from the new Dietary Guidelines,” Dave Parker, president of the National Association of Wine Retailers, said in a statement released by the White House. “Moderate consumption has long been the foundation of the proper relationship with alcohol, and we are very pleased to see that the U.S. Department of Health and Human Services did not succumb to the call by extremist anti-alcohol groups to throw the idea of moderate consumption under the bus,” he said. To be clear, the Trump administration isn’t encouraging people to drink more alcohol. But its new guidance removes specific recommended limitations for daily alcohol consumption that were previously in place. “Consume less alcohol for better overall health,” the document says. “People who should completely avoid alcohol include pregnant women, people who are recovering from alcohol use disorder or are unable to control the amount they drink, and people taking medications or with medical conditions that can interact with alcohol. For those with a family history of alcoholism, be mindful of alcohol consumption and associated addictive behaviors.” Reuters reported on Thursday that federal officials under Biden administration had been preparing to issue even stricter alcohol recommendations than what was previously in place by suggesting that both men and women limit their consumption to one drink per day. The Trump administration decided to go in a different direction, however. Trump’s marijuana rescheduling order, which directs the attorney general to quickly finish the process of moving marijuana to Schedule III, earned him praise from much of the cannabis community, even if there’s broad consensus that the substance should be removed from the CSA entirely and be treated similar to alcohol. However, the administration hasn’t been consistent on its messaging around marijuana, with the Drug Enforcement Administration (DEA) promoting content linking cananbis use to depression and suicidal thinking and echoing talking points from prohibitionists. Regardless, Americans are increasingly opting for cannabis over alcohol, which is tied to a substantial amount of deaths annually. A recent poll found that more U.S. adults set New Year’s resolutions to cut down on alcohol and tobacco, rather than marijuana, for example. Younger Americans are also increasingly using cannabis-infused beverages as a substitute for alcohol—with one in three millennials and Gen Z workers choosing THC drinks over booze for after-work activities like happy hours. Another survey released in October found that a majority of Americans believe marijuana represents a “healthier option” than alcohol—and most also expect cannabis to be legal in all 50 states within the next five years. Smoking marijuana is also associated with “significantly” reduced rates of alcohol consumption, according to a recent federally funded study that involved adults smoking joints in a makeshift bar. A study published last year found that adults who drink cannabis-infused beverages has found more evidence of a “substitution effect,” with a significant majority of participants reporting reduced alcohol use after incorporating cannabinoid drinks into their routines. Another survey released last year also showed that four in five adults who drink cannabis-infused beverages say they’ve reduced their alcohol intake—and more than a fifth have quit drinking alcohol altogether. The post Trump Administration Ditches Alcohol Limit Guidance As Marijuana Remains Federally Criminalized appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The governor of Kentucky says he’s “not satisfied” with the time it’s taken to launch the state’s medical marijuana program, but he anticipates that the pace of patient access will “pick up significantly” in 2026—and that progress includes the new approval of the first cannabis processor business for operations. Gov. Andy Beshear (D) gave an update on the medical marijuana system during a briefing on Thursday, saying that the processor’s approval means “multiple products” will become “available in the coming weeks for eligible Kentuckians.” Also this month, the governor said he expects two additional dispensaries will open their doors “once additional product becomes available.” The state’s first medical cannabis dispensary launched last month, and Beshear said he expects another dispensary to open this month. “Our priorities are ensuring Kentuckians suffering from serious medical conditions like cancer, PTSD or multiple sclerosis can have access to medical cannabis as soon as possible,” he said. “We have the cultivators. We now have a processor. And we have dispensaries. This should greatly speed up product coming to dispensaries around the state,” Beshear said. “And I know it feels like it’s taken a long time, but the rules were very specific about how it had to be grown, how it had to be processed if it was going to be in certain products.” “While none of us are satisfied that there is not more product there yet, what we have done is to create a highly regulated, safe system that’s going to operate pretty smoothly as product comes online,” he said. The governor said he’s optimistic the state will see “full operation” of the cannabis program, possibly by the middle of the year. “This was a promise we made. This is a promise we’re keeping.” Later in the briefing, in response to a reporters’ question, Beshear reiterated that he’s “not satisfied” with the time it’s taken to keep that promise, and he wants “to speed it up.” “We’re pushing for it, but the crops have got to grow. It’s got to be processed,” Beshear said. “The restrictions inside the law were aimed at a very secure system, which is important, but that also meant it took a little more time than we would have liked. I expect it to pick up significantly, but I’m not going to be satisfied until we’re at 100 percent.” The governor, who has long championed cannabis reform, previewed the market launch last month, while making the case that medical marijuana will help thousands of patients find an alternative to opioids for pain management. He made much of crossing a 15,000 patient registration milestone in late October, but that’s evidently grown meaningfully in recent weeks. Beshear previously acknowledged that “it’s taken longer than we would have liked” to stand up the industry since he signed medical marijuana legalization into law in 2023. In recognition of that delayed implementation, he signed an executive order to waive renewal fees for patients who get their cards this year so that they don’t get charged again before retailers open. And another order he signed providing protections for qualified patients who obtain medical marijuana outside of Kentucky “will stay in place.” Beshear separately announced in May that the state had launched a new online directory that lets people see where medical cannabis dispensaries will be opening near them. He emphasized that the state has been working to deliver access to patients “at the earliest possible date,” and that involved expediting the licensing process. Last January, the governor also ceremonially awarded the commonwealth’s first medical marijuana cards. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, the governor sent a letter to Kentucky’s congressional delegation last year, “urging them to take decisive action to protect the constitutional rights of our law abiding medical cannabis patients” by repealing the federal ban on gun possession by people who use marijuana. That came after bipartisan Kentucky senators filed legislation that similarly called on the state’s federal representatives to take corrective action, which Beshear said he supports but would like to see even more sweeping change on the federal level. The federal Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) warned Kentucky residents in 2024 that, if they choose to participate in the state’s medical marijuana program, they will be prohibited from buying or possessing firearms under federal law. Health practitioners have been able to start assessing patients for recommendations since the beginning of last December. While there currently aren’t any up-and-running dispensaries available to patients, Beshear has further affirmed that an executive order he signed in 2023 will stay in effect in the interim, protecting patients who possess medical cannabis purchased at out-of-state licensed retailers. During the November 2024 election, Kentucky also saw more than 100 cities and counties approve local ordinances to allow medical cannabis businesses in their jurisdictions. The governor said the election results demonstrate that “the jury is no longer out” on the issue that is clearly supported by voters across partisan and geographical lines. The post Kentucky Governor ‘Not Satisfied’ With Medical Marijuana Access Rollout, But Expects Pace To ‘Pick Up Significantly’ In 2026 appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A GOP congressman says President Donald Trump made it “very clear” his administration should move forward with rescheduling marijuana, and so he isn’t concerned about the possibility that the Justice Department will delay or ignore the recent directive to complete the process. Rep. Dave Joyce (R-OH), co-chair of the Congressional Cannabis Caucus, told Marijuana Moment on Thursday that he doesn’t think Attorney General Pam Bondi would seek to undermine the president’s executive order to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) despite any personal reservations she may have. The congressman—who attended the Oval Office signing ceremony for the rescheduling order last month and has sponsored or cosponsored a number of marijuana reform bills over recent sessions—said Trump “was pretty clear about what he wanted and where he wants to go, so I can imagine it’s a good opportunity—the rescheduling of it—to be able to do the things that are necessary to study it and figure out, good or bad, what the impacts are.” “Certainly the ability exists to reschedule,” Joyce, who has also sponsored legislation to give cannabis businesses access to the banking system, said. The Department of Justice has not yet commented on its place for the rescheduling process, which was initiated under the Biden administration. DOJ representatives have not responded to multiple inquires from Marijuana Moment about the department’s intentions or the potential timeline for finalizing the reclassification rule. Bondi, who opposed efforts to legalize medical cannabis in Florida as state attorney general, also did not appear at Trump’s signing ceremony for the rescheduling order. If the pending proposal was to federally legalize cannabis, the congressman said that “might have been a different subject matter” for Bondi. But simply rescheduling marijuana—which would free up certain research barriers and allow state-legal cannabis businesses to take federal tax deductions—is a simpler matter. “At this point, obviously, if they asked certainly I’d give my input. But the attorney general is certainly competent,” he said, adding that he’s confident “we’ll be able to work this through.” Asked about a recent Congressional Research Service (CRS) report that discussed how DOJ could, in theory, reject the president’s directive or delay the process by restarting the scientific review into marijuana, Joyce reiterated that “the president made it very clear what his intent was in doing this, so that’s why we want to follow through with it.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, the U.S. House of Representatives on Thursday approved a spending bill that would continue protecting state medical marijuana programs from federal intervention—while excluding a provision that previously advanced to block the Justice Department from rescheduling cannabis. If federal officials follow through on Trump’s executive order directing the reclassification of marijuana, it could also free up Washington, D.C. to finally legalize recreational cannabis sales after a years-long congressional blockade. Separately, the Drug Enforcement Administration (DEA) recently said that a marijuana rescheduling appeal process “remains pending” despite the president’s order directing the attorney general to finish the job “in the most expeditious manner.” An agriculture-focused conservative nonprofit connected to a PAC linked to the president recently applauded the rescheduling order, arguing that it will “destroy” the illicit market and support seniors and military veterans who could benefit from cannabis. Also, a coalition of Republican state attorneys general have criticized Trump’s rescheduling decision, saying cannabis is “properly” classified as a Schedule I drug with no accepted medical use and a high potential for abuse. Last month, groups of House and Senate Republican lawmakers also sent letters urging Trump not to reschedule cannabis. Trump, however, dismissed those concerns—pointing out that an overwhelming majority of Americans support the reform and that cannabis can help people who are suffering from serious health issues, including his personal friends. The LCB contributed reporting from Washington, D.C. The post GOP Congressman Dismisses Concerns About Marijuana Rescheduling Delay, Saying Trump Made It ‘Very Clear’ DOJ Must Act appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Florida lawmaker has introduced a new bill to legalize recreational marijuana that also aims to break up what he calls “monopolies” in the state’s current medical cannabis program by revising the business licensing structure. The legislation, filed by Sen. Carlos Guillermo Smith (D), comes as the state Supreme Court reviews the constitutionality of proposed adult-use legalization initiative that an industry-funded campaign is seeking to place on the November ballot. Under the new bill, adults over 21 years of age could legally possess up to four ounces of smokable marijuana or cannabis products containing up to 2,000 milligrams of THC. Medical cannabis patients would be allowed to grow up to six flowering plants at home for personal use. Medical marijuana businesses that apply for adult-use licenses could begin selling cannabis for recreational purposes beginning next January. “We can’t call ourselves the ‘Free State of Florida’ while continuing to criminalize cannabis use by grown adults,” Smith told Marijuana Moment on Thursday, adding that a majority of voters approved a legalization initiative at the ballot in 2024 that wasn’t enacted after “falling just short of the state’s arbitrary 60 percent threshold.” “The message from voters was unmistakable: they want change,” he said. “Senate Bill 1398 answers that call by legalizing cannabis for adults 21 and over in a safe, responsible, and tightly regulated way.” “It also ends state-created medical marijuana monopolies by opening the market to small businesses and gives Floridians the freedom to cultivate their own cannabis if they choose,” the senator said. “It’s time for the Legislature to stop ignoring the will of the people, end draconian criminalization laws, and finally deliver a fair, legal, and accountable cannabis system for Florida.” Under the new bill, current medical cannabis dispensaries—known as medical marijuana treatment centers (MMTCs)—could apply for retail licenses to sell recreational marijuana. And only cannabis purchased from licensed businesses would be legal to possess. People with prior convictions for activity made legal under the bill would also be given an opportunity for resentencing and expungement. The legislation stipulates marijuana and paraphernalia would be exempt from being taxed—but only for medical cannabis patients and caregivers. Additionally, local governments would be able to levy a business tax on dispensing facilities. There’s been some criticism among advocates about the current medical marijuana system, specifically around the idea that vertical integration and licensing caps have effectively created a marijuana monopoly in the state. In an attempt to address that issue, the bill would break out licensing categories. In contrast to the current system of seed-to-sale businesses, regulators would offer individual licenses to cultivate, manufacture, transport and sell cannabis products. There isn’t a specific mandate for an increase in the number of licensed marijuana businesses, but the measure would direct the state Department of Health to adopt rules on “procedures and requirements for…the registration and registration renewal of MMTCs.” Depending on the outcome of that rulemaking process, new businesses could enter the market. Also, registered cultivator and processors would be able to do wholesale transactions with other MMTCs, which is not currently permitted under Florida’s medical cannabis program. The legislation would also task the Department of Agriculture and Consumer Services to adopt rules adopt “regulating the cultivation of marijuana by members of the public for their private use, including rules regulating the use of a cooperative model for cultivation.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Here’s an overview of additional Florida marijuana developments: A state lawmaker recently introduced a bill that would protect the parental rights of medical cannabis patients, preventing them from losing custody of their children for using their medicine in accordance with state law. A pro-legalization GOP lawmaker filed legislation to amend state law to codify that the public use of marijuana is prohibited. Rep. Alex Andrade (R), the sponsor, said last year that embracing cannabis reform is a way for the Republican party to secure more votes from young people. Last month, a Florida Republican senator filed a bill to expand the state’s medical marijuana program, in part by increasing supply limits for patients and waiving registration fees for honorably discharged military veterans. A similar version of legislation was introduced in the House. Other recently filed bills in the legislature for 2026 would more incrementally reduce medical cannabis patient registration fees for military veterans and clarify that smoking or vaping marijuana in public places is prohibited. A Florida Democratic senator introduced legislation for the 2026 session that would legalize home cultivation of marijuana for registered medical cannabis patients in the state. In the background, a campaign is working against the clock to collect enough signatures to again put the question of adult-use marijuana legalization to voters at the ballot. But there have been complications. Most recently, the Republican attorney general of Florida and several business and anti-marijuana groups urged the state Supreme Court to block the legalization initiative, calling it “fatally flawed” and unconstitutional. The attorney general’s office last month asked the state Supreme Court to review the constitutionality of the legalization initiative. The court accepted the request and set a schedule for state officials and the cannabis campaign to file briefs this month. Proponents of the measure have until January 12 to submit response briefs, then the opposition has until January 20 to reply. The briefs were filed days after Smart and Safe Florida filed a new lawsuit against state officials, alleging that they improperly directed the invalidation of about 71,000 signatures as a turn-in deadline approaches. In March, meanwhile, two Democratic members of Congress representing Florida asked the federal government to investigate what they described as “potentially unlawful diversion” of millions in state Medicaid funds via a group with ties to Gov. Ron DeSantis (R). The money was used to fight against the 2024 citizen ballot initiative, vehemently opposed by the governor, that would have legalized marijuana for adults. The lawmakers’ letter followed allegations that a $10 million donation from a state legal settlement was improperly made to the Hope Florida Foundation, which later sent the money to two political nonprofits, which in turn sent $8.5 million to a campaign opposing Amendment 3. The governor said last February that the newest marijuana legalization measure is in “big time trouble” with the state Supreme Court, predicting it would be blocked from going before voters this year. “There’s a lot of different perspectives on on marijuana,” DeSantis said. “It should not be in our Constitution. If you feel strongly about it, you have elections for the legislature. Go back candidates that you believe will be able to deliver what your vision is on that.” “But when you put these things in the Constitution—and I think, I mean, the way they wrote, there’s all kinds of things going on in here. I think it’s going to have big time trouble getting through the Florida Supreme Court,” he said. In 2023, the governor accurately predicted that the 2024 cannabis measure from the campaign would survive a legal challenge from the state attorney general. It’s not entirely clear why he feels this version would face a different outcome. While there’s uncertainty around how the state’s highest court will navigate the measure, a poll released last February showed overwhelming bipartisan voter support for the reform—with 67 percent of Florida voters backing legalization, including 82 percent of Democrats, 66 percent of independents and 55 percent of Republicans. Separately, Florida medical marijuana officials are actively revoking the registrations of patients and caregivers with drug-related criminal records. The policy is part of broad budget legislation signed into law last year by DeSantis. The provisions in question direct the state Department of Health (DOH) to cancel registrations of medical marijuana patients and caregivers if they’re convicted of—or plead guilty or no contest to—criminal drug charges. The post New Florida Bill Would Legalize Recreational Marijuana And End ‘Monopolies’ In Medical Cannabis With Expanded Business Licensing appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The mention of Women Grow and Tokeativity is like a breath of fresh air. I love how women are using social media and meetups to not only push for cannabis legalization but also gender equality. Flux 2

Rescheduling could let DC legalize marijuana sales; MA anti-cannabis initiative challenge; Study: CBD combats tumors; OH’s $1 billion in sales Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The House of Representatives passed a spending bill containing a provision to continue protecting state medical cannabis laws from federal interference and without a separate rider that would have blocked the Trump administration from rescheduling marijuana. Federal marijuana rescheduling in line with President Donald Trump’s recent executive order could have an outsized impact on Washington, D.C. by letting the city finally move forward with legalizing recreational cannabis sales—but there’s a possible catch. The Massachusetts State Ballot Law Commission scheduled a hearing for next week to consider a complaint alleging that an anti-marijuana campaign for an initiative to roll back the state’s legalization law “obtained signatures fraudulently.” A new scientific review concluded that “CBD exhibits multi-targeted anti-tumor effects by disrupting key cancer hallmarks.” “Cannabidiol…demonstrates promising antitumor effects by inhibiting cancer growth, metastasis, and angiogenesis, while also alleviating cancer-related symptoms such as pain and nausea.” The Ohio Division of Cannabis Control reported that dispensaries sold more than $1 billion worth of legal recreational and medical marijuana products in 2025. / FEDERAL The House bill to create a pathway for patients to use Schedule I drugs got one new cosponsor for a total of 12. / STATES Kentucky Gov. Andy Beshear (D) noted the launch of medical cannabis sales in his State of the Commonwealth speech. Washington, D.C. Mayor Muriel Bowser (D) touted the 100th closure of an unlicensed cannabis business since enforcement legislation went into effect. A Virginia senator is resigning to take a position as senior advisor to the Cannabis Control Authority. California regulators published guidance on avoiding cannabis business disputes. Oklahoma regulators issued guidance on acceptable forms of medical cannabis patient ID. Michigan regulators are accepting hemp grower registration applications. Washington State regulators will host a feedback session on draft cannabis advertising rules on Friday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL British Columbia, Canada’s premier said the province is not considering decriminalizing public drug use when its current pilot project is up for renewal at the end of this month, though it’s not clear if officials will seek to extend drug decriminalization in any form. The UK National Police Chiefs’ Council issued medical cannabis guidance. / SCIENCE & HEALTH A study of rats found that “CBD demonstrates neuroprotective effects against blast-induced behavioral changes, with preventive administration more effective than post-injury treatment.” A study suggested that “cannabinoids have distinct antibacterial effects on certain pathogens associated with persistent endodontic infections.” A study of bread found that “10–15 % hemp flour offers optimal nutritional and technological balance.” / ADVOCACY, OPINION & ANALYSIS Prohibitionist organization Smart Approaches to Marijuana published an “impact report.” / BUSINESS Curaleaf Holdings, Inc. is moving to redomesticate to Delaware. Canopy Growth Corporation entered into a series of transactions to recapitalize its balance sheet and extend the maturity dates of all outstanding indebtedness to January 2031 at the earliest. Missouri retailers sold $124.8 million worth of legal marijuana products in November. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Federal medical cannabis protections approved in Congress (Newsletter: January 9, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Okay, venues, venues everywhere! Searching the globe, eh? Reminds me of organizing my sister's surprise party. Finding the right spot was a total headache! We almost settled for a bowling alley. I remember when I had a similar location issue. I was planning a charity event and the initial venue fell through just weeks before. It was crazy trying to find a replacement that fit our budget and style. My friends thought I needed a Love Tester just to handle the stress. Let's hope you have better luck than I did then!

Just saw this Oregon Cannabis Industry Meetup announcement. Sounds like a great opportunity to network. Wonder if the guest speaker will drop some knowledge bombs, maybe even reveal a hidden strategy, like mastering the angles in 8 Ball Pool for business success. If anyone's going, let's connect beforehand!

This Tokeativity Q&A with Laganja Estranja is fascinating! Learning about her journey from drag to cannabis advocacy is inspiring. It's amazing how she balances art and activism. Makes you think about challenging norms, like trying that difficult level in Snow Rider . Her story shows how being true to yourself can lead to success in unexpected fields. Tokeativity provides a great platform for these conversations.

The U.S. House of Representatives has approved a spending bill that would continue protecting state medical marijuana programs from federal intervention—while excluding a provision that previously advanced to block the Justice Department from rescheduling cannabis. Following bicameral negotiations on the appropriations package, the House advanced it in a 397-28 vote on Thursday, sending it to the Senate for consideration. Advocates and industry stakeholders were encouraged to see the rescheduling language stripped from the final deal after it had been approved by the House Appropriations Committee last year, as well as the preservation of a longstanding rider preventing DOJ from using its funds to interfere in state medical marijuana laws. The legislation that’s now advancing to the Senate covers Fiscal Year 2026 spending for Commerce, Justice, Science, and Related Agencies (CJS), Interior, Environment and Energy and Water Development. The move comes weeks after President Donald Trump issued an executive order directing Attorney General Pam Bondi to expeditiously complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). Here’s the language of the provision advanced by the House but excluded from the latest agreement: “SEC. 607. None of the funds appropriated or other wise made available by this Act may be used to reschedule marijuana (as such term is defined in section 102 of the Controlled Substances Act (21 U.S.C. 802)) or to remove marijuana from the schedules established under section 202 of the Controlled Substances Act (21 U.S.C. 812).” GOP senators have separately tried to block the administration from rescheduling cannabis as part of a standalone bill filed in 2023, but that proposal did not receive a hearing or vote. Meanwhile, on Monday, the Drug Enforcement Administration (DEA) said a marijuana rescheduling appeal process “remains pending” despite Trump’s executive order. The House-passed appropriations package also contains a rider that’s been annually renewed since 2014 barring the Justice Department from using its funds to interfere in the implementation of state medical marijuana laws. However, for reasons that are unclear, the rider that lists each state that would be protected excludes Nebraska. Here’s the text of that provision: “SEC. 531. None of the funds made available under this Act to the Department of Justice may be used, with respect to any of the States of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming, or with respect to the District of Columbia, the Commonwealth of the Northern Mariana Islands, the United States Virgin Islands, Guam, or Puerto Rico, to prevent any of them from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana.” Missing from the latest version is an addition to that rider that the House previously included that would have authorized enhanced penalties for sales near schools and parks. That provision specifically stipulated that the Justice Department could still enforce a section of U.S. code that calls for increased penalties for distributing cannabis within 1,000 feet of an elementary school, vocational school, college, playground or public housing unit. However, a joint explanatory statement for the spending package also says Congress “directs the Department to appropriately enforce the Federal Drug-Free School Zones Act (2 1 U.S.C. 860), to ensure that areas with young children, including schools and playgrounds remain drug-free.” That appears to be related to a report from the Senate committee that was released last year stating that the medical marijuana protection rider “does not explicitly preclude” U.S. attorneys from enforcing a federal statute on selling or manufacturing controlled substances in “areas with young children, including schools and playgrounds.” The bill also maintains protections for state industrial hemp research programs under the 2014 Farm Bill: “SEC. 530. None of the funds made available by this Act may be used in contravention of section 7606 (‘Legitimacy of Industrial Hemp Research’) of the Agricultural Act of 2014 (Public Law 113–79) by the Department of Justice or the Drug Enforcement Administration.” Advocates may welcome the exclusion of the rescheduling provision and inclusion of medical marijuana protections in the CJS bill, but many cannabis stakeholders have protested Trump’s signing of a separate appropriations measure in November that includes provisions to ban most consumable hemp products. However, when the president issued the marijuana rescheduling order last month, he also directed Congress to reevaluate that policy and ensure that people can continue to access full-spectrum CBD products. A federal agency will also be moving to cover such products for certain patients under Medicare and Medicaid. The post US House Passes Bill Protecting State Medical Marijuana Laws And Rejecting Attempt To Block Trump’s Rescheduling Move appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Massachusetts election officials have scheduled a hearing to investigate a complaint challenging the signature gathering process for a proposed ballot initiative to roll back the state’s marijuana law. This comes about two weeks after the Secretary of the Commonwealth’s Elections Division confirmed that the anti-cannabis campaign collected enough valid signatures to send the measure to lawmakers for consideration ahead of potentially being placed on the November ballot. Opponents of the initiative submitted a complaint to the secretary’s office last week, arguing that the campaign “obtained signatures fraudulently.” The State Ballot Law Commission has now put a pre-hearing conference on the calendar for January 12, and a formal hearing will take place on January 13. “Paid signature gatherers at Trader Joe’s in Hanover, Market Basket facilities in Plymouth, Whole Foods in Weymouth and in parking lots around Gillette Stadium in Foxborough have misled voters with respect to what they were signing and thus obtained signatures fraudulently,” the filing states. “Among the misleading statements were assertions that the law proposed on the petition blanks they were signing would get fentanyl off the streets, provide affordable housing in their communities or fund public parks,” the filing, which was first reported by State House News Service, says. “Each of these assertions would be apt with respect to one or more of the other initiative petitions approved by the Attorney General, but have nothing to do with Initiative Petition 1E.” “The paid signature gatherers in question often provided voters only the backside of Petition 1E to those whose signatures they obtained. The backside does not bear the summary of the proposed law. All those circulating the signatures for payment were assigned numbers that would enable them to be identified and collected signatures from multiple cities and towns.” “All signatures collected in the manner described above, whether by the particular individuals who gathered signatures at the locations described above or by other circulators are the subject of this objection,” the complaint, filed by attorney Thomas Kiley, concludes. Wendy Wakeman, the chair committee backing the anti-cannabis proposal, told State House News Service that petitions were “collected with integrity.” “We stand by the number,” she said. Secretary of the Commonwealth William Galvin (D) said that the complaints are “based on the people who now are in retail cannabis businesses.” “They’ve got to come up with enough signatures knocked off to disqualify the petition. It has to be based on evidence, it can’t be assertions. So it’s going to be a challenge,” he said. “You’re talking tens of thousands of signatures, to come up with enough that are going to be disqualified in a short period of time, because the Ballot Law Commission is time limited, 10 days, I think. So good luck. I hope they have a nice time.” The state last month certified 78,301 signatures for the petition, titled “An Act to Restore a Sensible Marijuana Policy.” The initiative would still let adults 21 and older possess and gift up to an ounce of cannabis, but it would repeal provisions of the voter-approved legalization law allowing for commercial sales and home cultivation by adults. The medical cannabis program would remain intact under the measure. As detailed in the recent complaint, the campaign has been marred with controversy over allegedly misleading signature gathering tactics. There have been claims that paid petitioners used fake cover letters for other ballot measures on issues like affordable housing and same-day voter registration. The state attorney general’s office has confirmed it’s received complaints to that end. And an association of state marijuana businesses urged voters to report to local officials if they observe any instances of “fraudulent message” or other deceitful petitioning tactics. The campaign has denied the allegations. Massachusetts Attorney General Andrea Campbell’s (D) office—which cleared the campaign for signature gathering in September—has stressed to voters the importance of reading their summary, which is required to go at the top of the signature form, before signing any petitions. The Massachusetts legislature received the initiative for consideration on Wednesday when the 2026 session kicked off. Unless it’s invalidated, lawmakers have until May 5 to act on the proposal. If they choose not to enact it legislatively, the campaign would need to go through another round of petitioning and get at least 12,429 certified signatures by July 1 to make the November ballot. Meanwhile, the head of Massachusetts’s marijuana regulatory agency recently suggested that the measure to effectively recriminalize recreational cannabis sales could imperil tax revenue that’s being used to support substance misuse treatment efforts and other public programs. Whether the cannabis measures make the cut is yet to be seen. Voters approved legalization at the ballot in 2016, with sales launching two years later. And the past decade has seen the market evolve and expand. As of August, Massachusetts officials reported more than $8 billion in adult-use marijuana sales. Meanwhile, Massachusetts lawmakers recently assembled a bicameral conference committee to reach a deal on a bill that would double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market. Last month, state regulators also finalized rules for marijuana social consumption loungues. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The state Cannabis Control Commission (CCC) recently launched an online platform aimed at helping people find jobs, workplace training and networking opportunities in the state’s legal cannabis industry. State lawmakers have also been considering setting tighter restrictions on intoxicating hemp-derived products and a plan to allow individual entities to control a larger number of cannabis establishments. Also in Massachusetts, legislators who were working on a state budget butted heads with CCC officials, who’ve said they can’t make critical technology improvements without more money from the legislature. Massachusetts lawmakers additionally approved a bill to establish a pilot program for the regulated therapeutic use of psychedelics. And two committees have separately held hearings to discuss additional psilocybin-related measures. Photo courtesy of Chris Wallis // Side Pocket Images. The post Massachusetts Officials Will Review Complaint That Anti-Marijuana Campaign ‘Fraudulently’ Collected Signatures For Ballot Initiative appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The escort service's priority is ensuring your identity is secure and protected. In this age of advanced smartphones and media, there is a chance that you could be a victim of another MMS scandal video that is very popular among night-time watchers. Nainital escort service escorts in Nainital Haldwani escort service Ramnagar escort service Rudrapur escort service Bhimtal escort service

I'm looking forward to treating you to a night of sexually explicit escorts for you at the Chandigarh accommodation or your central Chandigarh apartment. The best part about your Chandigarh outcall escorts is that they can delight their partners. Chandigarh escort service Dehradun escort service Chandigarh escorts Ahmedabad escort service Ajmer escort service Jaipur escort service Jodhpur escort service

To encounter them for all intents and purposes; what you need to do is call us or drop an email to make your booking. One additional thing, if you are coming to Dehradun from some other region of the nation and the world, at that point you can make an advance booking. Whenever you visit Dehradun do not forget to hire our call girls in Dehradun. Dehradun Call girls Dehradun call girl Bhimtal Call girls Rishikesh Call girls Dhanaulti Call girls Haridwar Call girls Mussoorie Call girls Nainital Call girls Haldwani Call girls Ramnagar Call girls Rudrapur Call girls Jaipur Call girls Ajmer escort service Jodhpur Call girls Udaipur Call girls Indore Call girls Pushkar Call girls Lucknow Call girls

Cannabidiol (CBD), a non-intoxicating compound in marijuana, “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties, a new scientific review Scientists explored CBD’s effect on many types of cancer—including some of the most aggressive ones, such as glioblastoma, which affects the brain. They also noted it can help suppressing the growth and metastasis of other cancers, including breast, lung, colorectal, ovarian and prostate, among others. “CBD exhibits multi-targeted anti-tumor effects by disrupting key cancer hallmarks,” they found. The paper, funded by National Natural Science Fund of China, was designed as a systematic review of previous studies evaluating the cancer fighting qualities of CBD. The idea behind much of the research is to study how cancer cells survive by hijacking normal biological signals like growth cues, stress responses and immune pathways. The novelty scientists found was that CBD doesn’t seem to target just one of these systems and instead nudges several of them at once, pushing cancer cells toward collapse through overlapping and complementary effects. In colon cancer models, for example, CBD interferes with a receptor called GPR55, which helps tumors grow and migrate. Blocking that receptor weakens a pathway cancer cells rely on to divide quickly, and in some cases makes tumors more responsive to chemotherapy. Other experiments show CBD dialing down genes linked to aggressive growth while switching on stress-related pathways that slow things down. Lung and breast cancers appear to respond in related but slightly different ways. In non-small cell lung cancer, combinations of CBD and THC reduce tumor growth by interfering with epithelial-mesenchymal transition, the process that allows cancer cells to spread. In breast cancer models, CBD has been shown to stop cells mid-cycle, trigger programmed cell death and activate autophagy, the cell’s internal recycling system turned destructive. “Cannabidiol (CBD), an FDA-approved and well-tolerated compound, demonstrates promising antitumor effects by inhibiting cancer growth, metastasis, and angiogenesis, while also alleviating cancer-related symptoms such as pain and nausea.” There are also practical challenges, however. CBD is poorly absorbed when taken by mouth and is heavily metabolized, which means only a fraction may reach tumor tissue. To get around this, scientists are exploring nanoparticle-based delivery systems designed to improve absorption, target tumors more precisely and minimize side effects. Looking ahead, researchers say progress will depend on careful, methodical work. Tools like single-cell sequencing could help clarify how different tumor populations respond to CBD. Well-designed clinical trials will be essential to determine whether the effects seen in the lab translate into benefits for patients, especially when CBD is used alongside standard treatments. The study’s authors, who are affiliated with medical schools throughout China, noted the need to further explore the promise of CBD’s anti-tumor properties. “Future trials must stratify patients by tumor type and molecular markers to establish correlations between dosing, timing, and efficacy,” they wrote. The paper, which was not peer reviewed, was published in the December 2025 issue of the scientific journal Phytomedicine. The new study follows a series of encouraging discoveries related to CBD’s properties. In 2025, for example, a paper published in the journal Pharmacology & Therapeutics, assessed a range of clinical and preclinical findings that the efficacy of chemotherapy drugs can be enhanced by medical marijuana. In a sign of greater acceptance of medical applications of cannabis, President Donald Trump’s choice to serve as the next White House drug czar has called medical marijuana a “fantastic” treatment option for seriously ill patients and said she doesn’t object to legalization, even if she might not personally agree with the policy. Also last year, a study found that “patients with cancer using cannabis report significant improvements in cancer-related symptoms.” The post CBD Has ‘Substantial Promise’ To Combat Tumors From Cancer, Scientific Review Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The 1xBet promo code for 2026 is 1XBIG2026. Find out how to use the code when registering to get up to $130 welcome bonus. When a coupon is in play, what you can do will be affected. 1xbet app promo code kenya

Retailers sold more than $836 million in recreational cannabis products last year, while medical marijuana sales exceeded $233 million. By Megan Henry, Ohio Capital Journal Ohio’s recreational marijuana sales surpassed more than $836 million in 2025, the first full year recreational sales were legal. Recreational sales started in August 2024 and the state’s total recreational marijuana sales were $1,091,250,807, as of January 3, according to the Ohio Department of Commerce Division of Cannabis Control. Ohioans voted to legalize marijuana in 2023 and recreational sales totaled more than $242 million in 2024. Ohio’s medical marijuana sales started January 14, 2019, and the state’s total medical marijuana sales were $2,293,970,758, as of January 3, according to the Division of Cannabis Control. Medical marijuana sales brought in more than $233 million in 2025. Ohio’s average marijuana prices are a bit lower now than they were compared to last year at this time. The manufactured sales average was $23.83 for the week ending in Jan. 3 compared to $26.66 for the week ending of January 4, 2025, according to the Division of Cannabis Control. There are 190 dual-use marijuana dispensaries in Ohio, meaning they can sell medical and non-medical marijuana, according to the Division of Cannabis Control. More than 130 Ohio municipalities and townships have moratoriums in place banning the sale of adult-use cannabis as of December 2, according to Ohio State University’s Moritz College of Law. Senate Bill 56 Ohio Gov. Mike DeWine (R) signed a bill into law last month that made various changes to the state’s voter-passed marijuana law, including adding crimes such as making it illegal to bring legally purchased marijuana from another state back to Ohio. DeWine signed Ohio Senate Bill 56, which is set to take effect in March. The bill also bans intoxicating hemp products. On the marijuana side, it will reduce the THC levels in adult-use marijuana extracts from a maximum of 90 percent down to a maximum of 70 percent, cap THC levels in adult-use flower to 35 percent, and prohibit smoking in most public places. The bill gets rid of protections against discrimination for housing, employment, and organ donation. It also allows police to have probable cause during traffic stops if someone is a known user of marijuana. The bill prohibits possessing marijuana in anything outside of its original packaging and criminalizes bringing legal marijuana from another state back to Ohio. It also requires drivers to store marijuana in the trunk of their car while driving. Ohioans for Cannabis Choice recently launched a referendum effort in an attempt to stop the law from taking effect. The initial signatures were submitted so now Ohio Secretary of State Frank LaRose (R) must verify the signatures and Ohio Attorney General Dave Yost (R) will also have to certify the petition summary is fair and truthful. If the petition passes those hurdles, organizers can begin canvassing to collect signatures. They’ll need 6 percent of the total number of votes cast in the most recent gubernatorial election (248,092). The group will also need 3 percent of an individual county’s gubernatorial turnout in 44 of Ohio’s 88 counties. Organizers will have 90 days from the date the governor filed the law with the secretary to collect the required signatures. The last referendum that passed in Ohio was when voters overturned an anti-collective bargaining law in 2011. This story was first published by Ohio Capital Journal. The post Ohio Dispensaries Sold More Than $1 Billion Worth Of Legal Marijuana In 2025 appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The 1xBet promo code for 2026 is 1XBIG2026. Find out how to use the code when registering to get up to $130 welcome bonus. When a coupon is in play, what you can do will be affected. 1xbet promo code free spins pakistan

If federal officials follow through on President Donald Trump’s recent executive order directing the reclassification of marijuana, it could free up Washington, D.C. to finally legalize recreational cannabis sales after a years-long congressional blockade. Moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) would not federally legalize marijuana, but it would have significant policy implications. While much of the industry and public attention has focused on how the reform would affect tax and research issues, the move could have an outsized impact on local policy in the nation’s capital. According to congressional analysts and other experts, a Schedule III reclassification would mean that D.C.—which for over a decade has been barred from using its appropriated funds to allow marijuana sales, despite voter approval of of a noncommercial legalization initiative and local elected officials’ support for adding retail sales—could finally create a regulated adult-use market. In a report published in 2024, the Congressional Research Service (CRS) said that while federal cannabis prohibition would still be the law of the land, it “would permit the District government, as a matter of local law, to authorize the commercial sale of recreational marijuana, establish market regulations, and levy marijuana taxes, among other policy options.” The reason that D.C. is restricted from enacting that regulatory reform—even as nearly half of the states in the U.S. have established adult-use cannabis markets—is because of a congressional spending bill rider championed by prohibitionist Rep. Andy Harris (D-MD) that deprives the District of the ability to expend its appropriated dollars to set up such a system. The rider specifically states that D.C. can’t use its own local funds to “legalize or otherwise reduce penalties associated with the possession, use, or distribution of any schedule I substance.” Moving marijuana to Schedule III would mean that part of the rider would no longer be applicable to cannabis. There is a complication, however, because the congressional provision that’s been annually renewed since 2014 also stipulates that the District of Columbia can’t use funds to legalize or reduce penalties for “any tetrahydrocannabinols derivative.” But that term isn’t clearly defined in the rider or anywhere else in federal law. “The continued prohibition on legalization of tetrahydrocannabinols derivatives by the District could lead to interpretive questions about whether a particular substance is legally marijuana, hemp, a tetrahydrocannabinols derivative, or something else,” the 2024 CRS report says. “Certain synthetic tetrahydrocannabinols remain illegal for recreational use under D.C. law, but it is not clear whether these synthetic substances would constitute derivatives,” it says. “In addition, although federal law defines marijuana and hemp to be exclusive of each other, a substance could conceivably be both a tetrahydrocannabinols derivative and marijuana or hemp as a matter of law.” One of the nation’s top cannabis advocacy groups, NORML, also posted an analysis in 2024 arguing that rescheduling could “open a door” for D.C. to finally legalize adult-use marijuana sales. The group suggested that the term tetrahydrocannabinols derivative “is unlikely to be interpreted by a court as inclusive of marijuana generally.” In 2021, the Government Accountability Office (GAO) separately responded to a congressional inquiry and affirmed that, even with the D.C. marijuana sales ban in place, local lawmakers there can still take steps to prepare for the potential creational of a regulated recreational marijuana market. Medical cannabis sales are already legal in D.C. Last March, the White House claimed that marijuana reform in Washington, D.C. is an example of a “failed” policy that “opened the door to disorder.” The Trump administration last year asked a federal court to dismiss a lawsuit from a D.C. hemp business challenging the federal government over the congressional budget restriction preventing cannabis sales. About three months after Capitol Hemp filed the suit in U.S. District Court for the District of Columbia, the Justice Department in September submitted a motion requesting dismissal of the case, largely on procedural grounds. The court agreed the next month. The post Trump’s Marijuana Rescheduling Order Could Let Washington, D.C. Finally Legalize Recreational Sales appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Great compilation — seeing sample patch notes and change logs was informative. Detailed changelogs demonstrate development seriousness and accountability. Real votes aligned with developer consistency. j cain numbing cream Helpful resource — I found clear guidelines on cross-server trading. Safe cross-server commerce expands market variety responsibly. Real player reviews supported those systems. low commission real estate brokerage Thanks for highlighting servers with clear and fair duel systems. Balanced PvP duels encourage competitive play without toxicity. Real votes corroborated fairness. situs toto 4d Custom latex apparel like this feels truly premium. The shine, fit, and personalization are outstanding. A second-skin fit makes all the difference. Worldwide delivery in 20 days is excellent. situs toto From East L.A. to Silver Lake, the 323 connects neighborhoods that define Los Angeles. situs slot1000 gacor I never realized how many iconic neighborhoods are covered by the 323 area code. Hollywood and Echo Park in the same code is amazing! situs toto

some genuinely choice content on this internet site , saved to my bookmarks Lakeside Drive Condo

This post was fantastic! I learned so much, and I’m excited for your future content. Thank you for sharing! Lorong Puntong Condo

NH marijuana legalization bill passes; HI proposal for cannabis on ballot; FL medical marijuana patients’ parental rights; New Year’s resolution poll Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. Kelly Pedrick of Flok: “At Flok, we believe exceptional regulatory technology starts with a deep understanding of the legislative environment shaping cannabis programs nationwide. We pledged our support to Marijuana Moment because timely, accurate insight into cannabis policy and legislation is essential for helping regulators navigate an evolving and complex landscape. By staying closely informed, we are better positioned to design trusted, adaptable solutions on Salesforce that meet regulators where they are, and where policy is heading.” If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Congressional Cannabis Caucus Co-chair Rep. Dina Titus (D-NV) is urging Sara Carter Bailey, who was confirmed this week as director of the White House Office of National Drug Control Policy, to back fully legalizing marijuana—going beyond the rescheduling order that President Donald Trump signed. The New Hampshire House of Representatives passed bills to legalize marijuana and allow medical cannabis dispensaries to convert to for-profit businesses. The chair of the Hawaii House Judiciary and Hawaiian Affairs Committee said he plans to file legislation to put marijuana legalization on the ballot for voters to decide after bills to enact the reform have repeatedly failed in recent sessions. A Florida representative filed a bill to protect medical cannabis patients’ parental rights, making it so courts could not “deny or otherwise restrict a parent’s custody of a child or the parent’s visitation rights or parenting time with a child based solely on the parent’s status as a qualified patient.” A new poll on New Year’s resolutions shows that more Americans intend to quit or reduce their use of alcohol or tobacco than want to abstain from or cut down on marijuana consumption in 2026. / FEDERAL The House bill to designate psychedelic therapy centers of excellence got one new cosponsor for a total of 22. / STATES Wisconsin lawmakers discussed the prospects for marijuana reform. A Nebraska senator said a proposed constitutional amendment to make it harder for lawmakers to amend voter-approved ballot initiatives would make it very difficult to implement medical cannabis legalization in a way that advocates support. A Delaware representative spoke about his bill to decriminalize public marijuana consumption. A Colorado House candidate founded a cannabis social equity organization. Illinois officials are accepting applications for $50 million in marijuana revenue-funded grants to support projects to aid communities harmed by the “negative consequences of the war on drugs.” New Jersey regulators sent a reminder about meetings this month to gather input on how cannabis social equity revenue should be allocated. California regulators sent updates on various cannabis issues. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL A Czech Republic cannabis legalization law took effect. Thai officials are planning to enact further restrictions on cannabis dispensaries. / SCIENCE & HEALTH A review concluded that “cannabinoids, especially CBD, may improve anxiety and sleep disturbances.” A study found that medical cannabinoids “exert multi-target neuroprotection in ischemic stroke.” A study concluded that “mushrooms have learned twice independently how to make the iconic magic mushroom natural product psilocybin.” / BUSINESS TerrAscend workers are accusing the company of unfair labor practices. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Trump drug czar pushed to back full cannabis legalization (Newsletter: January 8, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I really appreciate this wonderful post that you have provided for us. I assure this would be beneficial for most of the people. kebuntoto This type of message always inspiring and I prefer to read quality content, so happy to find good place to many here in the post, the writing is just great, thanks for the post. slot online Hi there! Nice post! Please tell us when I will see a follow up! evostoto Pretty nice post. I just stumbled upon your weblog and wanted to say that I have really enjoyed browsing your blog posts. After all I’ll be subscribing to your feed and I hope you write again soon! evostoto I’m going to read this. I’ll be sure to come back. thanks for sharing. and also This article gives the light in which we can observe the reality. this is very nice one and gives indepth information. thanks for this nice article... togel 4d センフォース

Wow, What an Outstanding post. I found this too much informatics. It is what I was seeking for. I would like to recommend you that please keep sharing such type of info.If possible, Thanks. togel online I wanted to thank you for this excellent read!! I definitely loved every little bit of it. I have you bookmarked your site to check out the new stuff you post. situs slot This is a great inspiring article.I am pretty much pleased with your good work.You put really very helpful information. Keep it up. Keep blogging. Looking to reading your next post. situs toto I read that Post and got it fine and informative. situs slot Nice to be visiting your blog again, it has been months for me. Well this article that i’ve been waited for so long. I need this article to complete my assignment in the college, and it has same topic with your article. Thanks, great share. situs slot センフォース